Factors associated with the dosing of edoxaban for stroke prevention in patients with atrial fibrillation from South Korea and Taiwan: 1-year data from the Global ETNA-AF Program-Reference-Cited by-同舟云学术

Factors associated with the dosing of edoxaban for stroke prevention in patients with atrial fibrillation from South Korea and Taiwan: 1-year data from the Global ETNA-AF Program

Published:2021-04-30 Issue:5 Volume:84 Page:485-490
ISSN:1726-4901
Container-title:Journal of the Chinese Medical Association
language:en
Short-container-title:

Author:

Chao Tze-Fan,Hong Keun-Sik,Lee Byung-Chul,De Caterina Raffaele,Kirchhof Paulus,Reimitz Paul-Egbert,Chen Cathy,Unverdorben Martin,Wang Chun-Chieh

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference21 articles.

1. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.;Kirchhof;Eur Heart J,2016

2. 2017 consensus of the Asia pacific heart rhythm society on stroke prevention in atrial fibrillation.;Chiang;J Arrhythm,2017

3. Effects of regional differences in Asia on efficacy and safety of edoxaban compared with warfarin–insights from the ENGAGE AF-TIMI 48 trial.;Shimada;Circ J,2015

4. Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.;Singer;J Am Heart Assoc,2013

5. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.;Wallentin;Circulation,2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prescribing Patterns and Outcomes of Edoxaban in Atrial Fibrillation Patients From Asia　― One-Year Data From the Global ETNA-AF Program ―;Circulation Reports;2024-03-08

2. Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry;Scientific Reports;2024-02-02

3. Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation;JACC: Asia;2023-10

4. Edoxaban treatment in atrial fibrillation in routine clinical care: One‐year outcomes of the prospective observational ETNA‐AF study in South Korean patients;Journal of Arrhythmia;2023-05-31

5. Effectiveness and Safety of Reduced and Standard Daily Doses of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation: A Cohort Study Using National Database Representing the Japanese Population;Clinical Epidemiology;2022-04